DeGolyer Donald W's Form 4 filing
Emergent BioSolutions Inc.EBS · filed Aug 13, 2025
- Accession no.
- 0001628280-25-040156
- Filed
- Aug 13, 2025
- Trade date
- Aug 12, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $67.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| DeGolyer Donald WCIK 0001583098 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | Common Stock | SSaleDisposed | −7,844 | $8.65F2 | −$67,850.6 | 137,659 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
All shares sold at an exact price of $8.6475.
Referenced by the price of 1 transaction in Table I.